Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Public ClinicalTrials.gov record NCT01714817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 (Abatacept) or Placebo on a Background of Mycophenolate Mofetil and Corticosteroids in the Treatment of Subjects With Active Class III or IV Lupus Nephritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate (Abatacept) for treatment of lupus nephritis when used on a background of Cellcept (mycophenolate) and prednisone (corticosteroids)
Study identification
- NCT ID
- NCT01714817
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 695 participants
Conditions and interventions
Conditions
Interventions
- BMS-188667 Biological
- Mycophenolate mofetil Drug
- Prednisone Drug
- Placebo matching with BMS-188667 Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 22, 2013 (Actual)
- Primary completion
- Nov 21, 2016 (Actual)
- Completion
- May 30, 2018 (Actual)
- Last update posted
- Feb 26, 2021
2013 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University Of Alabama At Birmingham (Uab) | Birmingham | Alabama | 35294 | — |
| Valerius Med Group & Res Ctr Of Greater Long Beach, Inc. | Long Beach | California | 90806 | — |
| East Bay Rheumatology Medical Group, Inc. | San Leandro | California | 94578 | — |
| University Of Connecticut Health Center | Farmington | Connecticut | 06030 | — |
| University Of Miami Miller School Of Medicine | Miami | Florida | 33136 | — |
| Integral Rheumatology & Immunology Specialists | Plantation | Florida | 33324 | — |
| Emory University. | Atlanta | Georgia | 30303 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| Tulane University School Of Medicine | New Orleans | Louisiana | 70112 | — |
| Brigham & Women'S Hospital | Boston | Massachusetts | 02115 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| Local Institution | Camden | New Jersey | 08103 | — |
| Suny Downstate Medical Center | Brooklyn | New York | 11203-2056 | — |
| Northshore Lij Health System | Great Neck | New York | 11021 | — |
| The Feinstein Institute For Medical Research | Manhasset | New York | 11030 | — |
| Hospital For Special Surgery | New York | New York | 10021-4892 | — |
| Local Institution | New York | New York | 10032 | — |
| University Of North Carolina At Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Shanahan Rheum & Immunotherapy, PLLC | Raleigh | North Carolina | 27617 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Paramount Medical Research & Consulting, Llc | Middleburg Heights | Ohio | 44130 | — |
| Rheumatology Consultants Pllc | Knoxville | Tennessee | 37909-1907 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University Of Utah Hospital | Salt Lake City | Utah | 84112 | — |
| Local Institution | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 123 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01714817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01714817 live on ClinicalTrials.gov.